Robert Harris Schwartz - Mar 8, 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
President and CEO, Director
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Mar 8, 2024
Transactions value $
$0
Form type
4
Date filed
3/12/2024, 08:48 PM
Previous filing
Aug 25, 2023
Next filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +21.5K +23.16% $0.00 114K Mar 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +127K $0.00 127K Mar 8, 2024 Common Stock 127K $36.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter.
F2 1/3 of the option shares vest and become exercisable on May 22, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.